Curve Therapeutics Secures £40.5 Million Series A Funding Led by Pfizer Ventures to Propel Cancer Drug Discovery Efforts

Curve Therapeutics, a pioneering biotechnology firm, announced a significant £40.5 million Series A funding round, led by Pfizer Ventures and joined ...

February 28, 2024 | Wednesday | News
Aizon Raises $20M in Series C Funding to Revolutionize Pharma Manufacturing

      Aizon, the AI SaaS provider transforming pharmaceutical manufacturing, announced today the closing of a $20 million...

February 09, 2024 | Friday | News
Alto's Brainy Bonanza: Neuroscience Powerhouse ANRO Unleashes $128.6M IPO Surge

In a move that adds an intriguing layer to the IPO dynamics, Alto has granted underwriters a 30-day option to scoop up an additional 1,206,000 shares of co...

February 02, 2024 | Friday | News
Lonza's CEO Albert M. Baehny Steers Company to Stellar Success in 2023, Defying Economic Headwinds with Robust Financial Performance and Ambitious Growth Initiatives

Robust sales of CHF 6.7 billion, delivering 10.9%1 CER sales growth CORE EBITDA of CHF 2 billion, resulting in a margin of 29.8% Continued growth inves...

January 26, 2024 | Friday | Company results
Pfizer Urges Shareholders to Decline TRC Capital's Below-Market Mini-Tender Offer

Pfizer does not endorse TRC Capital Investment’s unsolicited mini-tender offer and recommends that stockholders do not tender their shares in respons...

January 11, 2024 | Thursday | News
QIAGEN Unleashes a Thrilling Windfall: Proposes a Whopping $300 Million Bonanza for Shareholders!

QIAGEN  announced a plan to return up to approximately $300 million (maximum EUR 273 million) to shareholders through a synthetic share repurchase tha...

January 08, 2024 | Monday | News
Goldman Sachs Raises $650M for West Street Life Sciences I

Inaugural strategy is one of the largest ever first-time private life sciences growth funds Fundraise closed above its original target, reflecting stron...

January 04, 2024 | Thursday | News
Lilly Completes Acquisition of POINT Biopharma

"Next generation radioligand therapies hold great promise for delivering meaningful advances against a range of cancers and we are excited to enter this sp...

December 28, 2023 | Thursday | News
XRP Healthcare, Burnratty Group Unveil African Healthcare Investment Opportunities

This investment opportunity offers a unique chance for individuals and institutions to actively participate in the growth and transformation of the healthc...

December 28, 2023 | Thursday | News
Inventiva Enrolls First Patient in China for NATiV3 Trial and Updates Clinical Development Program

The first patient was randomized in China in the NATiV3 Phase III clinical trial, triggering a milestone payment of $3 million from CTTQ to Inventiva.&nb...

December 21, 2023 | Thursday | News
ImpriMed Secures $23M in Series A to Expand AI-Powered Cancer Treatment Technology

ImpriMed, a leading precision medicine startup focused on leveraging artificial intelligence to improve cancer treatment,  announced the close of a $2...

December 20, 2023 | Wednesday | News
Parse Biosciences Secures $50M for Global Growth

Parse Biosciences, a leading provider of easily accessible and scalable solutions for single-cell sequencing, announced today that the company has raised $...

December 18, 2023 | Monday | News
Freya Biosciences Raises $38M in Significant Series A for Women’s Reproductive Immunotherapies

Series A led by Sofinnova Partners and OMX Ventures Freya Biosciences, a trans-Atlantic biotech company specializing in women's health, announced today a ...

December 12, 2023 | Tuesday | News
GSK Awards $1M in COiMMUNITY Initiative Grants to Support Adult Immunization and Health Equity

Ten projects will receive funding to help address adult immunization gaps in communities across the country GSK launched the COiMMUNITY Initiative in Ju...

December 12, 2023 | Tuesday | News

Survey Box

Poll of the Week

Which area of biopharmaceutical research excites you the most?

× Please select an option to participate in the poll.
Processing...
× You have successfully cast your vote.
 {{ optionDetail.option }}  {{ optionDetail.percentage }}%
 {{ optionDetail.percentage }}% Complete
More polls
Stay Connected

Sign up to our free newsletter and get the latest news sent direct to your inbox

© 2025 Biopharma Boardroom. All Rights Reserved.

Show

Forgot your password?

Show

Show

Lost your password? Please enter your email address. You will receive a link to create a new password.

Back to log-in

Close